THE EUROPEAN LEAGUE AGAINST RHEUMATISM (EULAR)

被引：0
|
作者：
Sherwood, D. [1 ]
机构：
[1] Thomson Reuters, London, England
来源：
DRUGS OF THE FUTURE | 2014年 / 39卷 / 08期
关键词：
Rheumatology; Arthritis; Lupus nephritis Rheumatoid arthritis; Osteoarthritis;
D O I：
10.1358/dof.2014.039.08.2213654
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
This year's Annual European Congress of Rheumatology, an annual conference organized by the European League Against Rheumatism (EULAR), took place in Paris, France. A new record of over 4,000 abstracts were submitted this year, and with at least 73,000 participants expected to attend from around the world, the congress has become a major event in the field of rheurnatology. The oral sessions, poster displays and lectures, presented by over 500 experts, cover wide range of topics, including the latest understanding of disease processes and recent advances in diagnosis and patient care.
引用
收藏
页码：597 / 601
页数：5
相关论文
共 50 条
  • [1] The European League Against Rheumatism (EULAR)-2018 Annual European Congress of Rheumatology
    Fur, J.
    [J]. DRUGS OF THE FUTURE, 2018, 43 (09) : 691 - 695
  • [2] The European League Against Rheumatism (EULAR)-2021 Annual European Congress of Rheumatology
    Tur, J.
    [J]. DRUGS OF THE FUTURE, 2021, 46 (09) : 749 - 754
  • [3] Classification and therapy of vasculitis according to recommendations of the European League Against Rheumatism (EULAR)
    Holle, J. U.
    Bley, T.
    Gross, W. L.
    [J]. RADIOLOGE, 2010, 50 (10): : 846 - 854
  • [4] Empfehlungen der European League Against Rheumatism (EULAR) zur Behandlung von „Großgefäßvaskulitiden“Recommendations of the European League Against Rheumatism (EULAR) for the treatment of “large-vessel vasculitides”
    E. Wipfler-Freißmuth
    F. Moosig
    M. Schirmer
    [J]. Zeitschrift für Rheumatologie, 2009, 68 : 260 - 263
  • [5] The European League Against Rheumatism (EULAR)-2020 Annual European E-Congress of Rheumatology
    Tur, J.
    [J]. DRUGS OF THE FUTURE, 2020, 45 (08) : 591 - 596
  • [6] The European League Against Rheumatism (EULAR)-18th Annual European Congress of Rheumatology
    Walker, K.
    [J]. DRUGS OF THE FUTURE, 2017, 42 (08) : 523 - 528
  • [7] European League Against Rheumatism (EULAR) recommendations and EULAR/American College of Rheumatology criteria - documenting progress in lupus
    Aringer, Martin
    Tektonidou, Maria G.
    Boumpas, Dimitrios
    Houssiau, Frederic
    [J]. RHEUMATOLOGY, 2021, 60 (06) : 2976 - 2978
  • [8] Recommendations for the content and conduct of European League Against Rheumatism (EULAR) musculoskeletal ultrasound courses
    Naredo, E.
    Bijlsma, J. W. J.
    Conaghan, P. G.
    Acebes, C.
    Balint, P.
    Berner-Hammer, H.
    Bruyn, G. A. W.
    Collado, P.
    D'Agostino, M. A.
    de Agustin, J. J.
    de Miguel, E.
    Filippucci, E.
    Grassi, W.
    Iagnocco, A.
    Kane, D.
    Koski, J. M.
    Manger, B.
    Mayordomo, L.
    Moeller, I.
    Moragues, C.
    Rejon, E.
    Szkudlarek, M.
    Terslev, L.
    Uson, J.
    Wakefield, R. J.
    Schmidt, A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (07) : 1017 - 1022
  • [9] Recommendations of the European League Against Rheumatism (EULAR) in the treatment of "large-vessel vasculitides"
    Wipfler-Freissmuth, E.
    Moosig, F.
    Schirmer, M.
    [J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2009, 68 (03): : 260 - +
  • [10] Therapiestrategien bei VaskulitidenEntsprechend den Empfehlungen der European League Against Rheumatism (EULAR) und der European Vasculitis Study Group (EUVAS)Therapy of vasculitidesAccording to recommendations of the European League Against Rheumatism (EULAR) and European Vasculitis Study Group (EUVAS)
    J.U. Holle
    F. Moosig
    W.L. Gross
    [J]. Der Internist, 2011, 52 (6): : 671 - 681
12345